Evogene Ltd Company Profile (NYSE:EVGN)

About Evogene Ltd

Evogene Ltd logoEvogene Ltd. (Evogene) is a biotechnology company for the improvement of crop productivity. The Company is engaged in developing seed traits for improved yield and abiotic stress tolerance, seed traits for biotic stress resistance, herbicides and bio-stimulants. The Company operates a seed business under its subsidiary Evofuel Ltd. (Evofuel). It operates through two segments. Its Evogene segment develops seed traits, ag-chemical products, and ag-biological products to improve plant performance. The Company's Evofuel segment develops species of the castor bean plant for second generation feedstock for biofuel and other industrial uses. Its Crop Enhancement (CE) division is developing two types of products: CE seed traits, are seed traits having improved yield and abiotic stress tolerance, and ag-biologicals, which focuses on microbial-based bio-stimulants. The Company's Crop Protection (CP) division is developing two types of products: CP seed traits and ag-chemicals.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NYSE
  • Symbol: EVGN
  • CUSIP:
Key Metrics:
  • Previous Close: $5.31
  • 50 Day Moving Average: $5.21
  • 200 Day Moving Average: $5.90
  • 52-Week Range: $4.86 - $8.06
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -14.27
  • P/E Growth: 0.00
  • Market Cap: $135.19M
  • Outstanding Shares: 25,459,000
  • Beta: 0.61
Profitability:
  • Net Margins: -235.47%
  • Return on Equity: -18.60%
  • Return on Assets: -17.16%
Debt:
  • Current Ratio: 17.05%
  • Quick Ratio: 17.04%
Additional Links:
Companies Related to Evogene Ltd:

Analyst Ratings

Consensus Ratings for Evogene Ltd (NYSE:EVGN) (?)
Ratings Breakdown: 1 Buy Rating
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $10.00 (84.46% upside)

Analysts' Ratings History for Evogene Ltd (NYSE:EVGN)
Show:
DateFirmActionRatingPrice TargetDetails
8/17/2016Credit Suisse GroupLower Price TargetOutperform$19.00 -> $10.00View Rating Details
11/19/2015Piper Jaffray CompaniesLower Price TargetNeutral$12.00 -> $8.00View Rating Details
(Data available from 2/22/2015 forward)

Earnings

Earnings History for Evogene Ltd (NYSE:EVGN)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/11/2016Q2($0.11)($0.18)$5.36 million$3.82 millionViewListenView Earnings Details
5/19/2016Q1($0.11)($0.13)$2.70 million$2.00 millionViewListenView Earnings Details
3/1/2016Q415($0.17)($0.22)$3.90 million$2.46 millionViewN/AView Earnings Details
11/18/2015Q315($0.15)($0.13)$3.50 million$3.31 millionViewListenView Earnings Details
8/5/2015Q215($0.19)($0.20)$4.40 million$2.66 millionViewN/AView Earnings Details
5/19/2015Q115($0.20)($0.13)$3.65 million$2.70 millionViewListenView Earnings Details
2/26/2015Q4($0.12)($0.19)ViewN/AView Earnings Details
11/10/2014Q314($0.11)($0.17)$4.20 million$3.16 millionViewN/AView Earnings Details
8/20/2014Q214($0.11)($0.22)$7.71 millionViewN/AView Earnings Details
5/8/2014Q1 14($0.12)($0.09)ViewN/AView Earnings Details
3/19/2014Q413($0.08)($0.20)$4.95 million$4.41 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Evogene Ltd (NYSE:EVGN)
Current Year EPS Consensus Estimate: $-0.6700 EPS
Next Year EPS Consensus Estimate: $-0.3800 EPS

Dividends

Dividend History for Evogene Ltd (NYSE:EVGN)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Evogene Ltd (NYSE:EVGN)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Latest Headlines for Evogene Ltd (NYSE:EVGN)
DateHeadline
globenewswire.com logoEvogene and ICL Innovation Sign Collaboration for Development of Crop Enhancers (NYSE:EVGN)
globenewswire.com - February 14 at 6:04 PM
finance.yahoo.com logoEvogene Fourth Quarter and Full Year 2016 Earnings Announcement Schedule (NYSE:EVGN)
finance.yahoo.com - February 13 at 8:58 AM
News IconCould Evogene Ltd (EVGN) See a Reversal After Having Formed Several Months Wedge Down Pattern (NYSE:EVGN)
randolphguide.com - February 7 at 3:10 AM
capitalcube.com logoETFs with exposure to Evogene Ltd. : January 20, 2017 (NYSE:EVGN)
www.capitalcube.com - January 20 at 6:20 PM
streetinsider.com logoEvogene (EVGN) to Move from NYSE to NASDAQ (NYSE:EVGN)
www.streetinsider.com - December 20 at 6:40 PM
us.rd.yahoo.com logo4:33 pm Evogene to transfer its stock exchange listing to the NASDAQ Global Market from the New York Stock Exchange (NYSE:EVGN)
us.rd.yahoo.com - December 20 at 10:10 AM
publicnow.com logoEvogene to Transfer Stock Exchange Listing to Nasdaq (NYSE:EVGN)
www.publicnow.com - December 20 at 10:10 AM
capitalcube.com logoEvogene Ltd. :EVGN-US: Earnings Analysis: Q3, 2016 By the Numbers : November 28, 2016 (NYSE:EVGN)
www.capitalcube.com - November 29 at 5:24 PM
capitalcube.com logoEvogene Ltd. :EVGN-US: Earnings Analysis: Q3, 2016 By the Numbers : November 28, 2016 (NYSE:EVGN)
www.capitalcube.com - November 29 at 5:24 PM
publicnow.com logoEvogene Reports Third Quarter 2016 Financial Results (NYSE:EVGN)
www.publicnow.com - November 21 at 9:53 AM
News IconEvogene Ltd. EVGN Financial and Strategic SWOT Analysis Review Prices from USD $300 (NYSE:EVGN)
www.bioportfolio.com - November 18 at 10:32 AM
streetinsider.com logoEvogene (EVGN) Announces Positive Efficacy, Stability Results from Ag-Biologicals Program Field Trial (NYSE:EVGN)
www.streetinsider.com - November 17 at 5:41 AM
finance.yahoo.com logoEvogene Announces Positive Field Trial Results in Ag-biologicals Program (NYSE:EVGN)
finance.yahoo.com - November 16 at 8:11 AM
finance.yahoo.com logoEvogene Third Quarter 2016 Earnings Announcement Schedule (NYSE:EVGN)
finance.yahoo.com - November 2 at 8:05 AM
4-traders.com logoEvogene : and IMAmt Sign Collaboration for Genomic Promoter Discovery and Validation in Cotton (NYSE:EVGN)
www.4-traders.com - October 20 at 10:25 AM
streetinsider.com logoEvogene (EVGN), IMAmt Enter Insect-Resistant Cotton Seed R&D Collaboration (NYSE:EVGN)
www.streetinsider.com - October 20 at 10:25 AM
finance.yahoo.com logoEvogene and IMAmt Sign Collaboration for Genomic Promoter Discovery and Validation in Cotton (NYSE:EVGN)
finance.yahoo.com - October 19 at 5:19 PM
finance.yahoo.com logo11:45 am (Thinly-Traded) Evogene and Instituto Mato-grossense do Algodo announce collaboration for the discovery and validation of novel genomic promoters to support IMAmt's product development of insect-resistant cotton varieties (NYSE:EVGN)
finance.yahoo.com - October 19 at 5:19 PM
publicnow.com logoEvogene Announces Joint Microbial Diversity Activity with University of Missouri (NYSE:EVGN)
www.publicnow.com - September 13 at 9:47 AM
finance.yahoo.com logoEvogene Announces Participation at the 18th Annual Rodman & Renshaw Global Investment Conference in New York City September 11-13th, 2016 (NYSE:EVGN)
finance.yahoo.com - September 1 at 4:50 PM
capitalcube.com logoETF’s with exposure to Evogene Ltd. : August 25, 2016 (NYSE:EVGN)
www.capitalcube.com - August 25 at 4:58 PM
streetinsider.com logoCredit Suisse Cuts Price Target on Evogene (EVGN) to $10 Following 2Q (NYSE:EVGN)
www.streetinsider.com - August 17 at 10:11 PM
capitalcube.com logoEvogene Ltd. :EVGN-US: Earnings Analysis: Q2, 2016 By the Numbers : August 15, 2016 (NYSE:EVGN)
www.capitalcube.com - August 15 at 5:02 PM
sg.finance.yahoo.com logoEvogene reports 2Q loss (NYSE:EVGN)
sg.finance.yahoo.com - August 11 at 5:03 PM
publicnow.com logoEvogene Reports Second Quarter 2016 Financial Results (NYSE:EVGN)
www.publicnow.com - August 11 at 5:03 PM
publicnow.com logoEvogene Appoints a New Member to Board of Directors and a New Chief Operating Officer (NYSE:EVGN)
www.publicnow.com - August 11 at 5:03 PM
publicnow.com logoEvogene to Participate at Piper Jaffray Global Agriculture Symposium (NYSE:EVGN)
www.publicnow.com - August 1 at 8:11 AM
publicnow.com logoEvogene Second Quarter 2016 Earnings Announcement Schedule (NYSE:EVGN)
www.publicnow.com - July 25 at 8:08 AM
finance.yahoo.com logoEvogene to Present at Crops and Chemicals 2016 Conference (NYSE:EVGN)
finance.yahoo.com - July 13 at 7:00 AM

Social

What is Evogene Ltd's stock symbol?

Evogene Ltd trades on the New York Stock Exchange (NYSE) under the ticker symbol "EVGN."

Where is Evogene Ltd's stock going? Where will Evogene Ltd's stock price be in 2017?

1 brokerages have issued twelve-month target prices for Evogene Ltd's shares. Their predictions range from $10.00 to $10.00. On average, they expect Evogene Ltd's stock price to reach $10.00 in the next year.

Who owns Evogene Ltd stock?

Evogene Ltd's stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include Menora Mivtachim Holdings LTD. (1.02%) and Stockman Wealth Management Inc. (0.15%).

Who sold Evogene Ltd stock? Who is selling Evogene Ltd stock?

Evogene Ltd's stock was sold by a variety of institutional investors in the last quarter, including Stockman Wealth Management Inc..

How do I buy Evogene Ltd stock?

Shares of Evogene Ltd can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Evogene Ltd stock cost?

One share of Evogene Ltd stock can currently be purchased for approximately $5.42.

Evogene Ltd (NYSE:EVGN) Chart for Wednesday, February, 22, 2017


Institutional Ownership Chart

Institutional Ownership by Quarter for Evogene Ltd (NYSE:EVGN)

Earnings History Chart

Earnings by Quarter for Evogene Ltd (NYSE:EVGN)

Dividend History Chart

Dividend Payments by Quarter for Evogene Ltd (NYSE:EVGN)

Last Updated on 2/22/2017 by MarketBeat.com Staff